Skeletal Muscle Membrane Permeability Markers Derived From 31 P‐MRS May Reflect Disease Activity in Becker Muscular Dystrophy
NMR in Biomedicine · 2025
DOI: 10.1002/nbm.70155 ↗Kurz gefasst
Fachartikel in der Zeitschrift NMR in Biomedicine, 2025. Verfasst von Esther J Schrama und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Leiden University Medical Center, Leiden, the Netherlands. Hauptthemen laut MEDLINE: Muscular Dystrophy, Duchenne, Muscle, Skeletal, Cell Membrane Permeability. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Netherlands Organisation for Health Research and Development (ZonMw), ZonMw.
Abstract (Originalsprache)
Replacement of muscle tissue by fat in patients with Becker muscular dystrophy (BMD), as measured by quantitative muscle MRI, has been shown to reflect disease progression, but this process is considered irreversible. To monitor treatment effects in healthy‐appearing muscles, biomarkers reflecting disease activity are needed. Here, we compare several candidate biomarkers for disease activity between patients with BMD and controls: intracellular ionised magnesium ([Mg 2+ ]), phosphodiesters (PDE), and weighted pH measures from phosphorus‐( 31 P)‐MRS; and membrane permeability derived from the random permeable barrier model (RBPM), as applied to diffusion‐tensor‐(DT)‐MRI data. We performed 7 T 31 P‐MRS and 3 T DT‐MRI in the left lower leg of 23 participants with BMD (mean [range] age: 41.1 [18.8–66.2] years) and 14 healthy controls (mean [range] age: 43.0 [21.2–63.6] years), estimating [Mg 2+ ], PDE/γ‐ATP, weighted pH and RPBM permeability. Follow‐up scans at 24 months were performed in a subset of these participants. Muscles in patients with BMD were regarded as likely to be ‘preserved’ (BMD pre ) with fat fractions ≤ 13.5% and as ‘progressing’ (BMD prog ) with 13.5% < fat fraction < 81.5%. Muscles with fat fractions ≥ 81.5% were excluded from further analyses. We observed decreased [Mg 2+ ] in BMD pre and BMD prog compared to healthy controls, whereas PDE/γ‐ATP and weighted pH were increased in these muscles. RBPM‐measured permeability did not differ between groups. We observed no longitudinal changes in [Mg 2+ ], PDE/γ‐ATP or weighted pH. Only [Mg 2+ ] continued to show group differences on inclusion of longitudinal data, and weighted pH demonstrated inter‐muscle differences. In patients with BMD, 31 P‐MRS demonstrates reduced [Mg 2+ ] and increased weighted pH in the lower leg muscles versus controls, suggesting greater membrane permeability—a potential disease activity biomarker independent of the disease phase. PDE/γ‐ATP was also significantly increased in progressing and preserved muscle. Incorporating 31 P‐MRS in therapeutic trials will help to further establish its use as a response biomarker.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Leiden University Medical Center, Leiden, the Netherlands.
- Duchenne Center Netherlands.
- Department of Human Movement Sciences, Faculty of Behavioural and Movement Sciences, VU University, Amsterdam, the Netherlands.
- C.J. Gorter MRI Center, Department of Radiology, Leiden University Medical Center, Leiden, the Netherlands.
- Department of Medical Imaging, Radboud University Center, Nijmegen, the Netherlands.
ORCID-Profile: Esther J Schrama, Melissa T Hooijmans, Nienke M van de Velde, Erik H Niks, Hermien E Kan, Donnie Cameron
Förderung
- Netherlands Organisation for Health Research and Development (ZonMw)
- ZonMw
Zitieren
APA
Schrama, E. J., Hooijmans, M. T., van de Velde, N. M., Niks, E. H., Kan, H. E., & Cameron, D. (2025). Skeletal Muscle Membrane Permeability Markers Derived From 31 P‐MRS May Reflect Disease Activity in Becker Muscular Dystrophy. NMR in Biomedicine. https://doi.org/10.1002/nbm.70155
Vancouver
Schrama EJ, Hooijmans MT, van de Velde NM, Niks EH, Kan HE, Cameron D. Skeletal Muscle Membrane Permeability Markers Derived From 31 P‐MRS May Reflect Disease Activity in Becker Muscular Dystrophy. NMR in Biomedicine. 2025. doi:10.1002/nbm.70155
BibTeX
@article{Schrama2025,
author = {Schrama, Esther J and Hooijmans, Melissa T and van de Velde, Nienke M and Niks, Erik H and Kan, Hermien E and Cameron, Donnie},
title = {Skeletal Muscle Membrane Permeability Markers Derived From 31 P‐MRS May Reflect Disease Activity in Becker Muscular Dystrophy},
journal = {NMR in Biomedicine},
year = {2025},
doi = {10.1002/nbm.70155}
}
EUVIMED